Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 3/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171653 | 0.83 | CA2 (0.61) | CA2CA12CA7CA14CA1 | |
| SCHEMBL19592287 | 0.81 | L3MBTL1 (0.50) | CA2CA12CA7CA14CA1 | |
| SCHEMBL22230834 | 0.80 | HTT (0.56) | CA2CA12CA14CA1CA9 | |
| SCHEMBL24767434 | 0.80 | CA2 (0.57) | CA2CA12CA7CA14CA1 | |
| SCHEMBL18594476 | 0.77 | CA12 (0.53) | CA2CA12CA7CA14CA1 | |
| SCHEMBL12256317 | 0.76 | CA12 (0.61) | CA2CA12CA7CA14CA1 | |
| SCHEMBL2112943 | 0.75 | CA2 (0.65) | CA2CA12CA7CA14CA1 | |
| SCHEMBL14191076 | 0.74 | KEAP1 (0.50) | CA2CA12CA1KEAP1CA9 | |
| SCHEMBL21536760 | 0.74 | CA2 (0.53) | CA2CA12CA7CA14CA1 | |
| SCHEMBL6660379 | 0.73 | MAPT (0.56) | CA2CA12CA7CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9563075-B2 | Method for manufacturing liquid crystal display device provided with front plate, and liquid crystal display device provided with front plate | Konica Minolta, Inc. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20130222720-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE PROVIDED WITH FRONT PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE PROVIDED WITH FRONT PLATE | KONICA MINOLTA , INC. (JP) | 2013-08-29 | — | — | US | disclosed |
| US-8445081-B2 | Polarizing plate protective film, polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2013-05-21 | — | — | US | disclosed |
| US-8062562-B2 | Method of producing a cellulose ester film | KONICA MINOLTA OPTO, INC. (JP) | 2011-11-22 | — | — | US | disclosed |
| US-7854864-B2 | Method for manufacturing an optical film having a convexoconcave structure | KONICA MINOLTA OPTO, INC. (JP) | 2010-12-21 | — | — | US | disclosed |
| US-7751005-B2 | Liquid crystal display apparatus | KONICA MINOLTA OPTO, INC. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-7598257-B2 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors | INCYTE CORPORATION (US) | 2009-10-06 | — | — | US | disclosed |
| US-20090202823-A1 | Cellulose Ester Film, Polarizing Plate and Display | MURAKAMI TAKASHI | 2009-08-13 | — | — | US | disclosed |
| US-20080084523-A1 | LIQUID CRYSTAL DISPLAY APPARATUS | KONICA MINOLTA OPTO, INC. (JP) | 2008-04-10 | — | — | US | disclosed |
| US-20080049324-A1 | Polarizing plate protective film, polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2008-02-28 | — | — | US | disclosed |
| US-20070252293-A1 | METHOD FOR MANUFACTURING AN OPTICAL FILM HAVING A CONVEXOCONCAVE STRUCTURE, OPTICAL FILM, WIRE GRID POLARIZER AND RETARDATION FILM | KONICA MINOLTA OPTO, INC. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-20070135461-A1 | 3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; immune-related diseases, skin disorders, myeloid proliferative disorders, cancer | INCYTE CORPORATION | 2007-06-14 | — | — | US | disclosed |
| US-20070092663-A1 | Cellulose ester film, polarizing plate and display | KONICA MINOLTA OPTO, INC. | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135461-A1 | 3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; immune-related diseases, skin disorders, myeloid proliferative disorders, cancer | JAK1, JAK3, MAP3K4 | CA2 4789/4885CA12 4874/4885CA7 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.